about
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinomaIdentification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cellsExosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction moleculesCancer of the prostate presenting with diffuse osteolytic metastatic bone lesions: a case reportSuppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasisSignificance of talin in cancer progression and metastasis.Preventing bone complications in advanced prostate cancerActivation of Rap1 promotes prostate cancer metastasisIncreased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formationTargeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancerBone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cellsLysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone.Cadherin-11 promotes the metastasis of prostate cancer cells to bone.Integrins in prostate cancer progressionCancer-Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer.Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone.Computational modeling of radiobiological effects in bone metastases for different radionuclides.SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.Is prostate cancer changing?: evolving patterns of metastatic castration-resistant prostate cancer.Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.The impaired viability of prostate cancer cell lines by the recombinant plant kallikrein inhibitor.Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer.Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil in vitro.Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer.Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.PPARγ activation reduces ischemia/reperfusion-induced metastasis in a murine model of hepatocellular carcinoma.Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression.
P2860
Q21260408-77CE6485-4E7A-4036-A854-E2188F507358Q24546102-7C3487E5-3515-4F23-94C7-AB8FE28EA834Q27333594-6DA67E50-1E3A-422A-AAF3-4F02FEDA79B3Q33405009-011BE53D-7FC9-469F-93D4-01846E6275CFQ33684159-8974F4FF-3819-4ED9-BDAB-9074EF989BA6Q33763551-6B926116-7D2F-4B93-BD31-046AE4A242B9Q34111634-EA136172-612B-47E2-A4D9-F91B7E73B937Q34332836-E035A9DD-E3D6-4E69-BCA6-513EEE44D1F0Q34649015-10061911-E7C5-4649-A299-5073BCF3B185Q35042977-4BC9DF7D-33E9-41CA-B00F-BD5809DB55AFQ35763903-0F04C3D8-05A3-4B9C-AF25-8573A94C71DDQ35976845-01F28F41-D612-42C5-BBE4-BB1E7311019FQ36025400-F7272E91-A8DE-4220-8CD2-42790DEA00C4Q36246902-BC3E0142-1FAA-4541-A4D7-985E4BC52BFCQ36677570-D47EA64C-2EDF-4D53-BB4E-B861D69CB519Q37100123-56CA2B25-1B27-4218-9F1B-0448D7BAF802Q37182177-5505C17D-3169-498B-ACF2-97DDC311E49CQ37200829-19FCD464-81AB-4B94-9C34-C48D3F276157Q37585138-796356F6-E020-43EA-9BF6-3573E5EEFFC4Q37591742-F0D60DAF-7584-48D4-A8CC-0283EC302AB3Q38861998-50D51E9E-E6B9-4047-84D5-69428128D1CBQ38918557-BBCDE0B1-161C-440E-9A67-3420CE60FA45Q39021336-08058E97-036C-4236-B24A-52AA21EB5678Q39115673-BB2EF0B8-3A9D-43A4-9E5B-E8DDB982BD5CQ39171940-CF4F40C8-3CA2-4FAA-B3AF-DFB4F9F61763Q39178333-F707AE1C-EC40-44F5-B2A2-0FDF6975B5E7Q39538019-83720DD5-B7CB-4937-A514-F6EBB918965CQ39547376-4009F3B4-DC21-4523-975C-DDA28CC7A017Q39586238-47031018-3BAC-47DC-8C63-742C0A48F561Q39948673-6AB13A3A-5AE4-46D4-A62D-51396C0A5738Q41761066-A3CF3B5E-E462-4D96-B6DA-7F4E572822C3Q41814914-E556FF66-9860-4BE5-BAF1-9901E1DF5F19Q42156375-F71DD681-362E-4BF9-B709-EB5114A49279Q44615001-2390D29F-6B98-4F63-9723-05F9E712D103
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Dynamic process of prostate cancer metastasis to bone.
@ast
Dynamic process of prostate cancer metastasis to bone.
@en
type
label
Dynamic process of prostate cancer metastasis to bone.
@ast
Dynamic process of prostate cancer metastasis to bone.
@en
prefLabel
Dynamic process of prostate cancer metastasis to bone.
@ast
Dynamic process of prostate cancer metastasis to bone.
@en
P2860
P356
P1476
Dynamic process of prostate cancer metastasis to bone
@en
P2093
Kwanchanit Tantivejkul
Linda M Kalikin
P2860
P304
P356
10.1002/JCB.10664
P577
2004-03-01T00:00:00Z